- 219 Downloads
Travellers’ diarrhoea (TD) is the most common illness of travellers to developing countries. In this chapter, we review the travel destinations with the highest incidence of TD, describe the main aetiologies and discuss the issues surrounding prevention and management of TD in some detail. We include discussion of current controversies regarding when self-treatment of TD with antibiotics should be advised. Chemoprophylaxis is rarely recommended, but we outline situations for which it may be considered. We also include a brief overview of management of diarrhoea in the returned traveller.
- Allen SJ, Martinez EG, Gregorio GV, Dans LF. Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst Rev. 2010;(11):CD003048.Google Scholar
- Arcilla MS, van Hattem JM, Haverkate MR, Bootsma MC, van Genderen PJ, Goorhuis A, et al. Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study. Lancet Infect Dis. 2017;17:78–85.CrossRefGoogle Scholar
- Connor B, Torresi J. Empiric management of acute TD abroad and in the recently returned traveler. In: Ericsson CD, DuPont HL, Steffen R, editors. Travellers diarrhoea. 2nd ed. Hamilton: BC Becker Inc.; 2007.Google Scholar
- Ng QX, Ho CYX, Shin D, Venkatanarayanan N, Chan HW. A meta-analysis of the use of rifaximin to prevent travellers’ diarrhoea. J Travel Med. 2017; 24(5).Google Scholar
- Riddle MS, Connor BA, Beeching NJ, DuPont HL, Hamer DH, Kozarsky P, Libman M, Steffen R, Taylor D, Tribble DR, Vila J, Zanger P, Ericsson CD. Guidelines for the prevention and treatment of travelers’ diarrhea: a graded expert panel report. J Travel Med. 2017;24(Suppl_1):S57–74.CrossRefGoogle Scholar